Mechanisms involved in the neurotoxic and cognitive effects of developmental methamphetamine exposure

Sarah A Jablonski1, Michael T Williams1, Charles V Vorhees1

  • 1Department of Pediatrics, Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Insights

Neonatal methamphetamine exposure causes significant neurotoxicity, leading to lasting cognitive deficits and altered brain function. This study investigates its impact on behavior, neurotransmission, and DNA damage.

Area of Science:

  • Neuroscience
  • Developmental Toxicology
  • Behavioral Science

Background:

  • In utero methamphetamine exposure causes cognitive deficits like attention and memory impairments.
  • The timing of exposure to teratogens significantly influences neuroanatomical and behavioral outcomes.
  • Third-trimester equivalent methamphetamine exposure in rodents leads to spatial navigation deficits.

Purpose of the Study:

  • To investigate the effects of neonatal methamphetamine-induced neurotoxicity.
  • To examine impacts on behavioral outcomes, neurotransmission, and receptor changes.
  • To assess alterations in plasticity proteins and DNA damage.

Main Methods:

  • Rodent models were used to study neonatal methamphetamine exposure.
  • Behavioral assessments were conducted to evaluate cognitive functions.
  • Neurotransmission, receptor binding, plasticity proteins, and DNA damage were analyzed.

Main Results:

  • Neonatal methamphetamine exposure resulted in significant neurotoxicity.
  • Observed were alterations in neurotransmission and receptor expression.
  • Changes in plasticity proteins and DNA damage were detected, indicating long-term effects.

Conclusions:

  • Neonatal methamphetamine exposure has profound and lasting neurotoxic effects.
  • These effects manifest as behavioral deficits and molecular changes in the brain.
  • Further research is needed to understand the full spectrum of developmental impacts.

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
122
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.2K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K